New standards may help push more drugmakers to use a synthetic product for critical drug safety testing, instead of one made from horseshoe crab blood that has long drawn criticism. The U.S.

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...

This article discusses current methods of endotoxin testing, its importance to the industry, sustainability issues relating to the process, and best practices. The potentially devastating effects of ...

It’s a bad week for horseshoe crabs as their defenders have failed to convince big pharma that synthetic crab blood is a viable alternative for endotoxin testing in drugs. Maryland-based US ...

Lonza has announced an expansion to its PyroTec® PRO Automated Robotic Solution for endotoxin testing. The new PyroWave® Reader add-on has been designed specifically for use with the sustainable ...

Hundreds of thousands of horseshoe crabs are used for endotoxin testing in the United States each year, bled for their blood’s ability to clot in the presence of toxins. An estimated 10 to 30 percent ...

This webinar will help the attendee gain an understanding of the requirements of current USP <85> Bacterial Endotoxin Test (BET) European Pharmacopoeia (Chapter 2.6.14) and the Japanese Pharmacopoeia ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, vice president, Technical at Parexel, discuss ...